EGFR and non-small cell lung carcinoma: In addition, MEG9 was significantly associated with hepatitis B virus (HBV) infection status in hepatocellular carcinoma (57), and epidermal growth factor receptor (EGFR) status in adenocarcinoma patients with non-small-cell lung cancer (NSCLC) (58).